CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder [Phase 4]
Summary
A Phase 4 study evaluating onabotulinumtoxinA (Botox) for social anxiety disorder was terminated, and results were posted in January 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daniel Lieberman | Conditions: Anxiety Disorder Social, Anxiety | Phase 4 | Status: TERMINATED | Results posted: 2019-01-23